Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Had a dream ZFGN hit last night. Deploying more Panzers.
Panzers eyeing new ZFGN data in a couple weeks
Panzers adding 3K starter position
Was hoping for an ETRM-like open today. Looks like it may open red instead.
* * $ZFGN Video Chart 01-06-17 * *
Link to Video - click here to watch the technical chart video
Had sold in the fives months ago and bought back in in the low 3's
Maybe this works out
Thanks...huge volume today.
Zafgen Raised to Market Outperform From Market Perform by JMP Securities
3 hours 35 minutes ago - DJNF
Ratings actions from Benzinga: http://www.benzinga.com/stock/ZFGN/ratings
(END) Dow Jones Newswires
January 06, 2017 06:39 ET (11:39 GMT)
Well.. I guess OREX is making a little comeback here.. but at least they have an obesity drug currently ( even if it has a tendency to cause suicidal thoughts )..
so maybe ZFGN will catch some sympathy.. even without a drug
maybe this is the place to get in, maybe not. Any stock that goes from $45.00 to $3.27 in a year is serious cause for concern. more likely to go .45 than back to $45.00 in the next year.. Purely speaking from a Statistical perspective.
on a positive note:
How much money does ZFGN have? enough to develop this 'New' drug take through trials??.. or will they need to do a capital raise?
Zafgen abandoned its lead drug, beloranib—an obesity treatment beset by safety problems—and will instead put its resources behind a follow-on preclinical obesity drug that it believes to be much safer. Xconomy spoke with CEO Tom Hughes about the decision, which is terrible news for patients with the rare disease Prader-Willi Syndrome; Zafgen had hoped to win FDA approval of beloranib in Prader-Willi, which would have made it the first marketed drug for the disease since human growth hormone over a decade ago. Shares of Zafgen fell more than 50 percent on the news.
So basically.. any buying of stock here is pure speculation that they will come up with a new drug? and re-invent themselves as a company. Crystal Ball sees a capital raise in future ?
people dying? really. sounds like there is risk for everyone involved with this stock.
scary stock, scary drug.. dangerous weight loss drugs out of fashion. IMO
I came here as the chart popped up on my radar from people pumping it on Twitter... and wanted to put on watch and start to DD. don't like the info I'm seeing.
Anything more than "hope" here? I'm open to being converted, someone enlighten, please.
Still not stable for reversal. May last some more days. On close watch...
I hope yall Listened to me lol weeeeeeeeee
Still holding here . Added @ 5.70 a few weeks back.
ZFGN$$$
Told Yall This Was Easy Money
Current $5.85/sh
Low float but lot of shorts. This could be a runner today. I smell a squeeze coming on.
Should be a big day here , up big in pre market!!
Bought first lot at 7.70 a few weeks back and doubled
Down at 5.90 a share last week.
Good news for sure !!
Drug sounds amazing, 11-13% weight loss? Might be huge catalyst.
It's definitely going to bring it down, maybe even lower than that
That could be just what I'm waiting for , I need it to fill the gap so I can buy in the $5. this news may just bring it down there..
Zafgen is Preparing to Mount a Beloranib Defense
http://marketexclusive.com/zafgen-is-preparing-to-mount-a-beloranib-defense/1765/
Unsure about third patient death. Two patient deaths confirmed. Third patient death just a rumor at this point. Does anyone have any information on this?
Patient death in October. Patient death in December. Class action lawsuit pending. I think the analyst are trying to recover losses.
Not enough volume to push this higher. Short lived bounce. Hoping to retest support with force and collapse chart.
Should be some short covering today, not many want to take the chance of holding over the weekend
You could be right if they can push it below $8.80 and keep it there. I bought a couple shares after hr yesterday at $9.11 and plan on selling pre market. Should be s interesting day here
I don't see that happening. This couldn't print intra-day highs Wednesday despite strong volume and never re-tested yesterday's pre-market highs. In fact, it never came close, despite green intermittently during the trading session. Classic trap to pull longs in. Trending yesterday was down. I see that continuing until we get a re-test of that $7.50 marker.
man thxs lol i get so tired of hearing about the evil short, shorts cover longs make money its that simple to me, and i don't short that ofeten...
I wouldn't short down here, it'll probably bounce in the morning
Without shorts there would be no market. It takes Bulls and bears to make a market. I use to think the same way, until I start shorting lol
Shorts are a despicable bunch. Hate them...but....in this market, I'm shorting anything with the kind of gain this one provided. Wanted to short in the pre, but brokerage wouldn't allow me to. Oh well. Target: $7.25. Only way to really be green as volatility reins these days.
GLTA
Nothing but hindsight in that chart. All that happens on the left side is meaningless as ZFGN proved today.
"Could go much higher", doh!
$$$ $ZFGN Video Chart Bullish Uptrend $$$
ZFGN Video Chart TA analysis
Red because it went 100% yesterday
Followers
|
21
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
335
|
Created
|
02/20/15
|
Type
|
Free
|
Moderators |
Clinical Trials - Zafgen
http://www.zafgen.com/zafgen/clinical-trials
ZAFGEN INC
ONE BROADWAY 8TH FLOOR
CAMBRIDGE, MA 02142
Phone: 617-401-3051
Fax: NA
Email: tgrazio@zafgen.com
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |